| A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata (NCT07762443) | Jiangsu vcare pharmaceutical technology co., LTD | 2026-09-30 |
| Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata (NCT07749716) | Jiangsu vcare pharmaceutical technology co., LTD | 2026-08-15 |
| A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of VC004 Capsules for Pain in Bone Metastases (NCT07731685) | Jiangsu vcare pharmaceutical technology co., LTD | 2026-07-30 |
| A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis (NCT07598383) | Jiangsu vcare pharmaceutical technology co., LTD | 2026-06-01 |
| Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis (NCT07592585) | Jiangsu vcare pharmaceutical technology co., LTD | 2026-05-12 |
| Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function (NCT07551570) | Jiangsu vcare pharmaceutical technology co., LTD | 2026-05-09 |
| Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function (NCT07551557) | Jiangsu vcare pharmaceutical technology co., LTD | 2026-04-29 |
| Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis. (NCT07172360) | Jiangsu vcare pharmaceutical technology co., LTD | 2025-12-26 |
| Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis (NCT07329101) | Jiangsu vcare pharmaceutical technology co., LTD | 2025-11-11 |
| Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo (NCT07172347) | Jiangsu vcare pharmaceutical technology co., LTD | 2025-10-31 |
| Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers (NCT07067775) | Jiangsu vcare pharmaceutical technology co., LTD | 2025-08-05 |
| The Mass Balance and Biotransformation Study of [14C] VC005 in Chinese Healthy Adult Male Volunteers (NCT06974292) | Jiangsu vcare pharmaceutical technology co., LTD | 2025-05-26 |
| Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis (NCT06891040) | Jiangsu vcare pharmaceutical technology co., LTD | 2025-04-28 |
| Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis (NCT06723080) | Jiangsu vcare pharmaceutical technology co., LTD | 2024-12-30 |
| A Clinical Trial to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects (NCT06619951) | Jiangsu vcare pharmaceutical technology co., LTD | 2024-09-18 |
| Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) (NCT06577519) | Jiangsu vcare pharmaceutical technology co., LTD | 2024-09-06 |
| Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects (NCT06529445) | Jiangsu vcare pharmaceutical technology co., LTD | 2024-07-22 |
| Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis (NCT06009094) | Jiangsu vcare pharmaceutical technology co., LTD | 2023-07-27 |
| Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis (NCT05997927) | Jiangsu vcare pharmaceutical technology co., LTD | 2023-07-20 |
| A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis. (NCT05874622) | Jiangsu vcare pharmaceutical technology co., LTD | 2023-06-12 |
| Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis. (NCT05814939) | Jiangsu vcare pharmaceutical technology co., LTD | 2023-04-26 |
| Assessment of the Effect of Omeprazole on Vicagrel in Healthy Subjects (NCT05651074) | Jiangsu vcare pharmaceutical technology co., LTD | 2022-11-14 |
| Food Effect Study on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects (NCT05528120) | Jiangsu vcare pharmaceutical technology co., LTD | 2022-10-20 |
| Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects (NCT05354752) | Jiangsu vcare pharmaceutical technology co., LTD | 2022-06-18 |
| PK/PD Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 Metabolizers (NCT05162053) | Jiangsu vcare pharmaceutical technology co., LTD | 2021-12-09 |
| Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects (NCT05138770) | Jiangsu vcare pharmaceutical technology co., LTD | 2021-11-18 |
| A Clinical Trial to Evaluate the Effect of Food on PK and PD of Vicagrel Capsules in Healthy Adult Subjects (NCT04919551) | Jiangsu vcare pharmaceutical technology co., LTD | 2021-08-24 |
| The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid Tumors (NCT04614740) | Jiangsu vcare pharmaceutical technology co., LTD | 2020-11-20 |
| The Mass Balance and Biotransformation of [14C] Vicagrel in Healthy Man (NCT04143750) | Jiangsu vcare pharmaceutical technology co., LTD | 2019-11-11 |
| Pharmacokinetics and Pharmacodynamics of Vicagrel in Healthy Adult Subjects of Different CYP2C19 (NCT03942458) | Jiangsu vcare pharmaceutical technology co., LTD | 2019-04-03 |
| The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel (NCT03599284) | Jiangsu vcare pharmaceutical technology co., LTD | 2018-08-30 |